ICAR-CIFE transfers the technology for Fish Vaccines against Bacterial Diseases, Edwardsillosis and Columnaris

28^th November 2022, Mumbai

ICAR-Central Institute of Fisheries Education, Mumbai has transferred the technologies of two fish vaccines developed against two major bacterial diseases, Columnaris caused by Flavobacterium columnare and Edwardsillosis caused by Edwardsiella tarda to Indian Immunological Private Limited (IIL), Hyderabad here today. IIL will develop the commercial-scale vaccines for use in fresh water fish.

These two vaccines are inactivated vaccines which will protect fish from these bacterial diseases.  The technologies were transferred in a non-exclusive mode. This is the first fish vaccine technology for bacterial diseases transferred by an ICAR institute to the industry.

Dr. C.N. Ravishankar, Director, ICAR-CIFE and Dr. K Anand Kumar, Managing Director, IIL signed the MoA on behalf of the respective organizations.

Dr. N P Sahu, Joint Director, Inventors, co-inventors, Chairperson, ITMU and other officials of ICAR-CIFE and IIL, Hyderabad were present during the occasion.

Inventors of the technology are Dr. Megha Kadam Bedekar (Principal Scientist, AEHM Division CIFE), Dr. Rajendran KV (Principal Scientist & Head, AEHM Division, CIFE), Dr. Kundan Kumar (Senior Scientist), Dr. Saurav Kumar (Scientist), Mrs. Puja Vinde (SRF), Dr. Gopal  Krishna (Former Director, ICAR- CIFE) and Dr. Gaurav Rathore (Principal Scientist & Head of Division, ICAR-NBFGR, Lucknow). I

ICAR Consortium Research Platform on Vaccines and Diagnostics funded the project.

(Source: ICAR-Central Institute of Fisheries Education, Mumbai)